Why is Medicamen Organ. falling/rising?

As of 24-Sep, Medicamen Organics Ltd is currently priced at 35.05, with no change in price (0.00%). The stock has recently outperformed its sector by 0.45%, but it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 62.96% compared to the 5-day average. Over the past week, the stock has increased by 2.94%, but it has seen a substantial decline of 14.51% over the past month and 34.97% year-to-date.
In the broader market context, the Sensex has experienced a decline of 1.08% over the past week, while Medicamen's performance has been relatively better in this timeframe. However, the stock's longer-term performance is concerning, with a 49.50% drop over the past year compared to the Sensex's decline of only 3.41%. This stark contrast highlights the challenges faced by Medicamen Organics Ltd in maintaining investor confidence and market stability, despite some short-term outperformance against its sector.